ArticleJournal of clinical & translational endocrinology2022

Use of real-world evidence data to evaluate the comparative effectiveness of second-line type 2 diabetes medications on chronic kidney disease.

Yu Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.